Pioglitazone Tablet
Product Images NDC 82804-111

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 82804-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean Change From Baseline For Hba1c In A 26-week Placebo-controlled Dose-ranging Study (observed Values) (Pioglitazone Fig1)

This is a figure showing the mean change from baseline for HbA1c in a 26-week placebo-controlled dose-ranging study. The graph displays the observed values over the weeks for different doses of a medication (15mg, 30mg, 45mg). The x-axis represents the weeks, while the y-axis shows the mean change in HbA1c.*

FDA Label Image

82804-111-30 (Pioglitazone Fig3)

This is a description of Pioglitazone 30mg tablets distributed by Proficient Rx LP. The tablets are white to off-white, round, and flat-faced with beveled edges. Each tablet is imprinted with "32" on one side and "H" on the other. It is essential to dispense the Medication Guide to each patient and store the medication at 20°-25°C (68°-77°F). The product is made in India and distributed by Rising Health, LLC.*

FDA Label Image

Chemical Structure (Pioglitazone Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.